#Pharmaceuticals — FinScans

News 📈 Stocks

Merck Shares Rally 87% as Pipeline Progress Outpaces Revenue Growth

September 20, 2026 (29 days ago)

Merck's 87% stock gain reflects investor confidence in its clinical pipeline and new product launches, even as revenue growth shows signs of…

MRK JNJ PFE

🌍 US Read More →

News 📈 Stocks

Ascendis Pharma Regains TransCon Rights After Novo Nordisk Collaboration Ends

September 19, 2026 (30 days ago)

Ascendis Pharma reclaims full control of its TransCon metabolic pipeline from Novo Nordisk, trading partnership security for the potential to capture higher…

ASND NVO

🌍 EUROPE Read More →

News 📈 Stocks

Novo Nordisk Initiates Cultural Reset to Counter Eli Lilly Market Gains

September 18, 2026 (30 days ago)

Novo Nordisk launches a 'Novo Way' corporate transformation to improve patient-focused commercialization and defend its market share against aggressive competition from Eli…

LLY NVO

🌍 GLOBAL Read More →

News 📈 Stocks

Pfizer Shares Consolidate at $28 as Non-COVID Growth Offsets Revenue Declines

September 18, 2026 (31 days ago)

Pfizer's Q2 earnings beat and 18% non-COVID growth highlight a successful business transition, yet shares remain range-bound as investors prioritize dividend stability…

PFE BMY MRK +2

🌍 AMERICAS Read More →

Analyst 📈 Stocks

UBS Sees 25% Upside for AstraZeneca After 15% Share Price Slide

September 18, 2026 (31 days ago)

UBS maintains a buy rating on AstraZeneca, arguing the recent 15% sell-off is overdone and highlighting the company's path to $80 billion…

AZN BMY ROG +1

🌍 EUROPE Read More →

News 📈 Stocks

AbbVie Shares Hover Near 52-Week High Amid SKYRIZI Growth Concerns

September 17, 2026 (31 days ago)

AbbVie shares trade near record highs, but reliance on SKYRIZI for one-third of revenue creates a concentration risk that could trigger volatility…

ABBV

🌍 AMERICAS Read More →

News 🌐 Macro — 📊 Neutral

Eli Lilly Shares Rise 1.6% as Berenberg Upgrades Stock to Buy With $1,400 Target

September 16, 2026 (32 days ago)

Eli Lilly stock gains 1.6% as Berenberg upgrades the pharmaceutical giant to Buy, citing strong growth prospects for its obesity and diabetes…

MindWalk Reports 21% Revenue Growth as ReefIQ AI Platform Scales

September 16, 2026 (32 days ago)

MindWalk pivots to partnership-based AI discovery, reporting 21% revenue growth and securing $30 million in financing to scale its ReefIQ platform across…

Novo Nordisk Rebrands to Novo to Boost Consumer Appeal Amid Market Rivalry

September 14, 2026 (34 days ago)

Novo Nordisk adopts the simplified 'Novo' brand identity as it pivots toward a more consumer-driven market strategy to regain its competitive edge…

NVO LLY

🌍 EUROPE Read More →

News 📈 Stocks

Millennium Management Doubles AbbVie Stake to 1.5 Million Shares

September 13, 2026 (36 days ago)

Millennium Management expanded its AbbVie holding to 1.5 million shares, signaling confidence in the pharmaceutical giant's dividend growth and diversified product portfolio.

ABBV

🌍 AMERICAS Read More →

News 📈 Stocks

Hair-Loss Drug Stocks Rally 500% as Investors Bet on Next Pharma Goldmine

September 13, 2026 (36 days ago)

Veradermics and Absci lead a surge in hair-loss drug stocks, though clinical risks and the lack of insurance coverage for cosmetic treatments…

MANE ABSI

🌍 AMERICAS Read More →

News 📈 Stocks

CRSP and VKTX: Two Biotech Stocks Poised for Growth in 2027

September 12, 2026 (36 days ago)

CRISPR Therapeutics and Viking Therapeutics offer strong long-term potential as clinical milestones and revenue recognition cycles align for 2027 growth.

CRSP VKTX

🌍 AMERICAS Read More →